As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheimer’s disease, efforts are being made in search of new molecules with anti-AChE activity. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.